Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published November 30, 2020

Advanced Nutriceuticals BPC-157 Vials Recall: Risk of Contamination

Advanced Nutriceuticals recalls BPC-157 vials due to lack of sterility assurance in production. Affected lots expire by December 2020. Consumers should not use these products.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0132-2021DrugAdvanced Nutriceuticals ›
Take action

Contact the company

Recalling firmAdvanced Nutriceuticals, LLC836 E 86th St · Indianapolis, IN 46240-1806
✎ GovInfoNow plain-language explainer

Advanced Nutriceuticals is recalling BPC-157 vials that may not be sterile. Using these vials could lead to infection or other health risks if the product is contaminated. Read more at govinfonow.com/recall/36633-advanced-nutriceuticals-bpc-157-vials-recall-risk-of-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/36633-advanced-nutriceuticals-bpc-157-vials-recall-risk-of-contamination · Updated October 4, 2026 · FDA enforcement record: FDA #D-0132-2021

Cite this page

“Advanced Nutriceuticals BPC-157 Vials Recall: Risk of Contamination.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36633-advanced-nutriceuticals-bpc-157-vials-recall-risk-of-contamination. Based on FDA recall #D-0132-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0132-2021%22&limit=1).

The FDA announced on November 30, 2020, that Advanced Nutriceuticals, LLC is recalling BPC-157 vials due to a lack of assurance of sterility. The agency issued the recall for products distributed in California, Colorado, Florida, Indiana, Kentucky, Ohio, and Texas.

How to tell if you have it

  • Brand: Advanced Nutriceuticals
  • Product: BPC-157, 2000 MCG/ML, 5 ML vial
  • Distributor: The Guyer Institute of Molecular Medicine, Indianapolis, IN
  • Lot #1102202009, Exp 12/08/2020
  • Lot #1105202009, Exp 12/20/2020
  • Lot #1110202001, Exp 12/15/2020
  • Lot #1112202004, Exp 12/12/2020

The hazard

The recall addresses concerns with production processes which cannot assure sterility of products intended to be sterile. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show the brand has been involved in other recent recalls of similar products, including Victory Medical Center Pharmacy Glutathione Vials Recall (2026-07-01), BD PurPrep Sterile Solution Recall (2026-04-22), and Reliance Bortezomib Injection Recall (2026-06-24).

How to tell if you have this one

Check for vials labeled 'BPC-157, 2000 MCG/ML, 5 ML' from The Guyer Institute of Molecular Medicine in Indianapolis. The affected lots include #1102202009 (exp 12/08/2020), #1105202009 (exp 12/20/2020), #1110202001 (exp 12/15/2020), and #1112202004 (exp 12/12/2020).

  • Brand
    Advanced Nutriceuticals
  • Category
    Drug
FDA recall event · 17 products

All 17 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    CA, CO, FL, IN, KY, OH, TX
Recall numberProduct, codes & lotsQuantity
D-0128-2021CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1029202004, Exp 11/29/2020; Lot #1102202001, 102202009, Exp 12/08/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202003, Exp 12/10/2020; Lot #1112202004, Exp 12/12/20206 vials
D-0129-2021FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1112202006, Exp 12/12/20201 vial
D-0130-2021PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1112202006, Exp 12/12/20201 vial
D-0131-2021AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1029202003, Exp 11/29/2020; Lot #1110202002, Exp 12/10/2020; Lot #1112202001, Exp 12/12/20203 vials
D-0132-2021BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1102202009, Exp 12/08/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202001, Exp 12/15/2020; Lot #1112202004, Exp 12/12/20204 vials
D-0133-2021THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #110220200, 1102202009, Exp 12/09/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202008, Exp 12/10/20204 vials
D-0134-2021IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot # 1029202005,Exp 11/29/2020; Lot #1102202014, Exp 12/08/2020; Lot #1112202002, Exp 12/12/20203 vials
D-0135-2021GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1112202008, Exp 12/11/20201 vial
D-0136-2021NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1113202002, Exp 01/13/2021; Lot #1102202005, Exp 12/08/20202 vials
D-0137-2021B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1111202001, Exp 01/11/20211 vials
D-0138-2021DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1111202002, Exp 12/11/20201 vial
D-0139-2021CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1110202004 Exp 12/10/20201 vial
D-0140-2021THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1110202005, Exp 12/10/2020; Lot #1102202015, Exp 12/08/2020; Lot #1105202009, Exp 12/20/20203 vials
D-0141-2021GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1030202010, Exp 11/30/20201 vial
D-0142-2021HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1029202007, Exp 12/29/201 vials
D-0143-2021LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1105202006, Exp 12/18/20201 vial
D-0144-2021Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN; Lot #1110202006, exp 12/10/20201 vial
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Vials Now

    Immediately discard any recalled BPC-157 vials that match the listed lot numbers and expiration dates.

Where it went and when

Where it was distributed

Distributed in 7 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: yesINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: not listedMOKentucky: yesKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: yesFL

FDA distribution: “CA, CO, FL, IN, KY, OH, TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Colorado, Florida, Indiana, Kentucky, Ohio, Texas.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Nov 30, 202012. FDA classified it Class II: Dec 11, 202023. Published in FDA’s Enforcement Report: Dec 23, 202032020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0132-2021 (November 30, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0132-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA